1. Home
  2. CTMX vs ESQ Comparison

CTMX vs ESQ Comparison

Compare CTMX & ESQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CytomX Therapeutics Inc.

CTMX

CytomX Therapeutics Inc.

HOLD

Current Price

$3.62

Market Cap

977.1M

Sector

Health Care

ML Signal

HOLD

Logo Esquire Financial Holdings Inc.

ESQ

Esquire Financial Holdings Inc.

HOLD

Current Price

$105.02

Market Cap

941.0M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
CTMX
ESQ
Founded
2008
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Commercial Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
977.1M
941.0M
IPO Year
2015
2017

Fundamental Metrics

Financial Performance
Metric
CTMX
ESQ
Price
$3.62
$105.02
Analyst Decision
Strong Buy
Buy
Analyst Count
10
3
Target Price
$12.10
$120.33
AVG Volume (30 Days)
2.9M
91.6K
Earning Date
05-08-2026
04-23-2026
Dividend Yield
N/A
0.76%
EPS Growth
N/A
14.20
EPS
N/A
1.40
Revenue
$76,201,000.00
N/A
Revenue This Year
N/A
$35.15
Revenue Next Year
$7.61
$39.09
P/E Ratio
$22.58
$75.00
Revenue Growth
N/A
N/A
52 Week Low
$1.72
$87.54
52 Week High
$8.21
$119.86

Technical Indicators

Market Signals
Indicator
CTMX
ESQ
Relative Strength Index (RSI) 30.72 45.08
Support Level $3.39 $104.58
Resistance Level $3.91 $111.41
Average True Range (ATR) 0.21 2.47
MACD -0.04 -0.28
Stochastic Oscillator 5.63 24.78

Price Performance

Historical Comparison
CTMX
ESQ

About CTMX CytomX Therapeutics Inc.

CytomX Therapeutics Inc a clinical-stage, oncology-focused biopharmaceutical company developing novel, masked, conditionally activated biologics designed to be localized to the tumor microenvironment. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.

About ESQ Esquire Financial Holdings Inc.

Esquire Financial Holdings Inc is a financial holding company operating as a full service commercial bank. It serves the financial needs of the litigation industry and small businesses nationally, as well as commercial and retail customers in the New York metropolitan area. The bank offers tailored financial and payment processing solutions to the litigation community and their clients as well as dynamic and flexible payment processing solutions to small business owners. It operates in one operating segment, that of community banking.

Share on Social Networks: